With March Madness in full swing, we decided to stick with what we know here at The Motley Fool, trading our basketball picks in for stock picks. We formed our own bracket filled with the top Big Pharma and Big Biotech stocks in a winner take-all tournament determined by the collective intelligence of our CAPS community.
This championship round matchup features�Celgene�and�Abbott Labs. Like the injury suffered to Louisville's Kevin Ware, Abbott is missing a key piece after the�spin-off�of AbbVie. Celgene is playing the role of Michigan, with a roster of known stars (Revlimid as Trey Burke), along with emerging talents (Abraxane as Mitch McGary).
Watch and find out which company cuts down the nets as health care's best stock.
Abbott Labs has changed forever after losing its branded pharmaceutical business to a spinoff. If you're a current investor, or might be buying shares soon, make sure you truly understand the stock by reading The Motley Fool's�brand new premium report�on Abbott Labs. The report outlines all of the must-know opportunities and risks, along with a full year of analyst updates to keep you up to speed. Best of all, you can claim this report today by�clicking here now.
Top 5 Long Term Companies To Watch For 2015: Youku.com Inc.(YOKU)
Youku.com Inc. operates as an Internet television company in the People?s Republic of China. Its Internet television platform enables consumers to search, view, and share video content across various devices. The company?s services for users comprise video content library consisting primarily of professionally produced content, including television serial dramas, movies, event reports, variety shows, and music videos under the Youku brand. It also provides user-generated content through Youku Paike and Youku Niuren programs; and produces a range of content, such as sponsored Web serial dramas, reality shows, interviews, and variety shows under Youku Originals brand. The company?s other services for users comprise online video search and discovery, online community, video space, real time commenting, and searchable community message board, as well as wireless video, iPhone channels and iPad, and P2P downloadable software client services. In addition, it offers online advert ising services to various advertising companies operating in fast moving consumer goods, information technology services, automobile manufacturing, electronics, telecommunications, financial services, e-commerce, and online game industries. The company?s products and services for advertisers and customers include online advertising services, such as in-video, display, sponsorship, and other forms of advertisements; targeting solutions; viral video advertisements; product placements; subscription-based services that enables users to watch advertisement-free premium content, such as high-definition movies; and sub-licensing content. It sells its advertising services through third-party advertising agencies comprising members of American Association of Advertising Agencies and Chinese advertising agencies. The company was formerly known as 1Verge Inc. and changed its name to Youku.com Inc. in June 2008. Youku.com Inc. was founded in 2005 and is headquartered in Beijing, the Peo ple?s Republic of China.
Advisors' Opinion:- [By Jayson Derrick]
According to T.H. Capital (reported on Thursday) Youku's (NASDAQ: YOKU) average daily video views for its TV dramas are likely to have fallen from 56 million in the previous quarter to 25 million in the first quarter. Shares lost 6.11 percent, closing at $25.81.
- [By Rick Munarriz]
However, the real development here is that fortifying its video offerings through iQiyi and PPS.tv will make Baidu a legitimate competitor to Chinese top dog Youku Tudou (NYSE: YOKU ) .
- [By Rick Aristotle Munarriz]
Alamy Companies can make brilliant moves, but there are also times when things don't work out quite as planned. From a software giant's dream CEO candidate telling them to keep dreaming, to the world's consumer tech leader at last getting its smartphone into the hands of the world's largest wireless carrier, here's a rundown of the week's best and worst results in the business world. Amazon.com (AMZN) -- Winner The leading online retailer was a loser in last week's column after its reputation took a hit in Europe. But it bounced back this week after Jeff Bezos went on "60 Minutes" Sunday and offered up a future of drone-shipped deliveries. We need to be realistic. A fleet of unmanned drones delivering shiny new Kindle Fire tablets isn't going to happen anytime soon. However, Bezos has once again positioned Amazon.com on the leading edge of e-tail. The maneuver got the media talking about Amazon, and that's free advertising during peak shopping season -- even if the drones never land on your doorstep. J.C. Penney (JCP) -- Loser The struggling department store chain can't seem to catch a break. It had initially encouraged investors by posting a 10.1 percent improvement in comparable-store sales for the month of November -- only the chain's second positive month since the end of 2011. However, investors lost their enthusiasm when comparing that showing to the nearly 32 percent plunge in comparable-store sales during last year's holiday quarter. In short, J.C. Penney still has a long way to go. Things got even more complicated on Thursday when the retailer revealed that it had received a letter of inquiry from the SEC. The trading regulator wants to take a closer look at J.C. Penney's liquidity and financial statements. It's just an inquiry, but it only creates more uncertainty. Chinese Internet Stocks -- Winners Investing in China's expanding Internet naturally carries a fair amount of political risk, but the world's most populous nation became a bit more at
5 Best Tech Stocks For 2014: Bazaarvoice Inc (BV)
Bazaarvoice, Inc., incorporated on May 25, 2005, connects businesses together to amplify the authentic voices of people where they shop. The Company�� solutions, which are primarily provided through Software as a Service (SaaS) platform, enable clients to capture and display online word of mouth about specific products and services, channel content into all the places where it will influence a purchase both within and outside its network, which it refers to as syndication, and use business insights so they can act on what consumers want.
Bazaarvoice Conversations Platform
The Company�� Conversations platform provides capabilities to capture, manage and display online word of mouth. Consumers interact with its solutions as they view or author consumer reviews, questions, photos, videos, long-format narratives and other forms of consumer-generated content. Content that is displayed by its Conversations platform is styled to match its clients��brand, preserving important branding elements of its clients��businesses. Content collected and managed by its Conversations platform is used by its clients in a range of applications, including their online Websites, mobile-optimized Websites, mobile applications, social networks, in-store kiosks, physical in-store displays, printed flyers, email and other forms of online and offline media. The Company�� Conversations platform allows clients to capture, manage and display consumer reviews about their products and services on their Websites and mobile-optimized Websites; allows clients to facilitate question and answer conversations between consumers, or between consumers and brand representatives, on their Websites; allows clients to collect consumer testimonials about their products and services and display these stories on their Websites; enables consumers to read or write reviews, product questions, product answers, or stories on its clients��pages on social networking Websites and easily share this content with the peopl! e they influence the most-their social network friends or followers, and provides third-party developers with tools to build products or extend its platform on behalf of its clients, which enables the Company to expand the use of its platform by leveraging applications built by third-party developers.
Bazaarvoice Connections Solutions
The Company�� Conversations clients are connected through its SaaS platform to form a network. The Company offers network syndication and brand engagement solutions to facilitate the sharing of online word of mouth among its clients and to enable brands to directly interact with consumers on its retail clients��Websites. BrandVoice enables brands to enter into distribution relationships allowing them to display review content from their brand Websites on retail Websites within its network, which it refers to as syndication. BrandAnswers enables brands to interact directly with consumers on retail websites within its network to answer questions and provide suggestions on alternative products that may better meet that consumer�� needs. Brand Response enables brands to interact with consumers by responding to reviews posted on retail Websites within its network.
Bazaarvoice Analytics Solutions
The Company�� Conversations platform includes its Intelligence solution, which is it enhanced analytics solution, and a Workbench Analytics solution, which provides analytics and self-service administration tools. Intelligence allows clients to derive sophisticated market, consumer and product insights in a timely manner from the underlying data it collects on their behalf through its platform. Workbench Analytics provides basic analytics capabilities that allow its clients to generate reports highlighting simple ratings trends, text analysis and product and service issue identification.
Bazaarvoice Media
The Company�� Bazaarvoice Media sells advertising on behalf of retailers, brands and agencie! s, and pr! ovides capabilities that incorporate consumers��authentic opinions in advertising campaigns, creating advertisements that are trusted, relevant and targeted. Bazaarvoice Media sells advertising on retail Websites, utilizing its relationships and knowledge of the intricacies of the retail environment. It develops custom programs for brands to reach consumers while they are in the shopping environment, while also selling to non-retail brands, such as within the automotive and financial industries, that wish to reach the engaged shopper within this channel. Word of Mouth Advertisements provides brands with the ability to increase engagement with their advertising through the inclusion of authentic consumer sentiment. Mobile Advertising enables brands to reach consumers on their mobile devices.
The Company competes with Pluck, Reevoo, Gigya, Viewpoints, Google and Facebook.
Advisors' Opinion:- [By Jake L'Ecuyer]
Bazaarvoice (NASDAQ: BV) tumbled 15.09 percent to $7.01 as the U.S. District Court in the Northern District of California ruled against the company's acquisition of PowerReviews.
5 Best Tech Stocks For 2014: Ubiquiti Networks Inc (UBNT)
Ubiquiti Networks, Inc. (Ubiquiti), incorporated on June 24, 2010, is a communications technology Company. designs, manufactures and sells broadband wireless solutions worldwide. The Company offers a portfolio of wireless networking products and solutions, including systems, high performance radios, antennas and management tools, designed for wireless networking and other applications in the unlicensed radio frequency (RF) spectrum. The Company offers solutions that incorporate its RF technology, antenna design and firmware technologies, which it refers to as AirTechnologies. It offers a portfolio of communications networking products and solutions and it recently introduced products in the video surveillance, wireless backhaul and machine-to-machine communication markets.
The Company�� business is driven by a community of network operators, service providers, distributors, value added resellers (VARs) and system integrators, which it refers to as the Ubiquiti Community. As of June 30, 2013, Ubiquiti�� AirTechnologies included, UBNT, airMAX, UniFi, mFi, EdgeMAX, airVision, airFiber, airOS, NanoStation, airGrid, NanoBridge, and a number of trademark applications and registrations in the United States and other countries. The Company technology enables it to provide end to end wireless networking solutions for network operators and service providers in underserved and underpenetrated markets. It designs its products and solutions using hardware and industry standard chipsets to enable these providers to deliver carrier class wireless broadband access and services to their subscribers.
Enterprise WLAN - UniFi
Unifi hardware utilizes MIMO technology, works with 802.11 standards, and uses a single cable for data transmission and power-over-ethernet. Unlike other enterprise Wi-Fi systems that utilize a hardware Wi-Fi switch, Unifi uses a virtual controller that allows for on-site management or remote management through the cloud. Each UniFi access point a! nd can be managed centrally with the UniFi Controller software. The UniFi Controller enables enterprise WLAN managers to centrally configure and administer a UniFi network and individual access points without any special training and through secure access from any Web browser. The UniFi Controller provides automatic UniFi access point detection, firmware updates, real-time status, map loading and advanced security options.
Video Surveillance - airVision
The H.264 cameras use a single cable for data transmission and power-over-ethernet. AirVision, its management controller software, can be used to manage multiple AirCam H.264 IP cameras as well as manage other digital video recorder devices. AirVision software is available for download at no cost on its Website and only manages Ubiquiti Network camera devices. Similar to its other network management products, airVision can be accessed securely from any Web browser, provides statistical reporting and analytics and provides a management console with camera settings and event recordings.
Machine-To-Machine Communication - mFi
In June 2012, the Company announced mFi, which includes hardware sensors, power devices, and management software that allows devices to be controlled remotely. For example, mFi allows users to manage and monitor their building temperature and power consumption. The management controller software is IP based and can be accessed from any browser locally or through the cloud. MFi software allows management to create rules using if/then statements to control numerous devices.
The Company competes with Motorola, Trango, Cisco Systems, Proxim, Mikrotikls, Senao, Ceragon Networks, DragonWave, Ruckus Wireless, TP-LINK Technologies CO., LTD, Andrew Corporation, PCTEL, Aruba Networks, Inc, Vivotek, Inc., Axis Communications AB , Mobotix Corp, Cambium Networks , SAF Tehnika, EnergyHub, Inc., AlertMe.com Ltd and Radio Waves Inc.
Advisors' Opinion:- [By Tom Bishop]
The company I have chosen is Ubiquiti (UBNT). By ��ireless networking,��I mean products that deliver carrier-class wireless networking performance for video, voice, and data.
- [By Mani]
Ubiquiti Networks, Inc. (NASDAQ:UBNT) shares have been in rally mode, particularly since reporting strong quarterly results in August, gaining 57 percent. Over the past three months, shares have climbed nearly 100 percent versus a 9 percent gain in the NASDAQ.
5 Best Tech Stocks For 2014: Rexahn Pharmaceuticals Inc (RNN)
Rexahn Pharmaceuticals, Inc. (Rexahn) is a development-stage biopharmaceutical company. The Company focuses on the development of cures for cancer to patients worldwide. The Company�� pipeline features one drug candidate in Phase II clinical trials. The Company also has several other drug candidates in pre-clinical development. In addition, the Company has two renal cell carcinoma (CNS) candidates, Serdaxin, CNS Disorders drug for depression and neurodegenerative diseases and Zoraxel, which is a erectile dysfunction (ED) and sexual dysfunction drug that are in clinical stages and the Company is are exploring options for further development . The Company�� drug candidate, Archexin is an anticancer Akt inhibitor.
Archexin
Archexin is potent inhibitor of the Akt protein kinase (Akt) in cancer cells. Archexin has FDA orphan drug designations for five cancers (RCC, glioblastoma, and cancers of the ovary, stomach and pancreas). Multiple indications for other solid tumors can also be pursued. Archexin inhibit both activated and inactivated forms of Akt, and to reverse the drug resistance observed with the protein kinase inhibitors. Archexin is an antisense oligonucleotide (ASO) compound that is complementary to Akt mRNA, and selective for inhibiting mRNA expression and production of Akt protein. As of December 31, 2011, Archexin was in Phase II clinical trials for the treatment of pancreatic cancer with enrollment completed in September, 2011.
Serdaxin
Serdaxin is an extended release formulation of clavulanic acid, which is an ingredient present in antibiotics approved by the FDA. The Company had been developing Serdaxin for the treatment of depression and neurodegenerative disorders. From January to September, 2011, the Company conducted a randomized, double-blind, placebo-controlled study compared two doses of Serdaxin, 0.5 milligram and 5 milligram, to placebo over an eight-week treatment period for major depressive disorder (MDD) patients. As of Dec! ember 31, 2011, the Company had not made a determination of Serdaxin�� future paths or resource allocations to further develop Serdaxin to treat MDD.
Zoraxel
Zoraxel is an orally administered, on-demand tablet to treat sexual dysfunction. Zoraxel is a dual enhancer of neurotransmitters in the brain that play a key role in sexual activity phases of motivation and arousal, erection and release, and may be the ED drug to affect all three of these phases of sexual activity. As of December 31, 2011, the Company was evaluating how to proceed with the Phase IIb study of Zoraxel.
The Company�� Pre-clinical Pipeline Drug Candidates includes RX-1792, which is a small molecule anticancer EGFR inhibitor; RX-5902, which is a small molecule anticancer ribonucleic acid (RNA) helicase regulator; RX-3117, which is a Small molecule anticancer deoxyribonucleic acid (DNA) synthesis Inhibitor; RX-8243, which is a small molecule anticancer aurora kinase inhibitor; RX-0201-Nano, which is a nanoliposomal anticancer Akt inhibitor; RX-0047-Nano, which is an nanoliposomal anticancer HIF-1 alpha inhibitor and RX-21101, which is a nano-polymer Anticancer.
Advisors' Opinion:- [By James E. Brumley]
At first glance, Rexahn Pharmaceuticals, Inc. (NYSEMKT:RNN) doesn't look like anything particularly trade-worthy. The stock's now where it was in late October, and where it was in late September, and even where it was in late June. In other words, though RNN has been much higher and much lower than its current price of $0.46 over the course of the past several months, it doesn't look like it's going anywhere - on a net basis - anytime.
No comments:
Post a Comment